CANNABIS SCIENCE - Revolution oder Verblendung ?
Seite 18 von 141 Neuester Beitrag: 25.04.21 01:13 | ||||
Eröffnet am: | 21.09.12 08:26 | von: Brokerface03. | Anzahl Beiträge: | 4.518 |
Neuester Beitrag: | 25.04.21 01:13 | von: Inesrhtla | Leser gesamt: | 722.638 |
Forum: | Hot-Stocks | Leser heute: | 183 | |
Bewertet mit: | ||||
Seite: < 1 | ... | 15 | 16 | 17 | | 19 | 20 | 21 | ... 141 > |
http://finance.yahoo.com/q?s=CBIS
mal sehen wie der SK ist heute!
schönes WE
The Company intends to seek the approval to issue a dividend of one share of Class A common stock for each one hundred shares owned by shareholders of record as of October 9, 2015. Both dividends will also carry a warrant that will give each shareholder of record a share purchase warrant consisting of an option to purchase one additional share of Class A common stock for each special dividend share received. Each warrant will be exercisable into one share of Class A stock at a price of $1.00 per share for a period of three months after all the proposed changes officially take effect. The Company also plans to apply for a unique and separate trading symbol for its shares of Class A common stock.
http://finance.yahoo.com/news/...ssue-dividend-payouts-133505908.html
ich bin dabei :)
http://finance.yahoo.com/news/...r-burgeoning-cannabis-131500630.html
Trotzdem: Wenn die Nasdaq winkt, dann scheint auch Potential da zu sein. Deshalb braucht man Kohle.
COLORADO SPRINGS, CO -- (Marketwired) -- 10/28/15 -- Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, is pleased to announce it will begin its dividend payout to its shareholders of record, as of December 31, 2010 and October 9 2015 respectively, triggering what the Company considers a "breakthrough drug development growth plan".
The Company will announce on Friday, October 30, 2015, the actual process for its shareholders to receive their dividend shares under the following two conditions:
(1) To issue a new dividend to holders of our current common stock so they received 1 share of Class A common stock and 1 non-transferable share purchase warrant for each 100 shares of our current class of common stock that they previously owned as of the record date, October 9, 2015. Each warrant will grant the holder to purchase an additional share of Class A common stock at a price of $1.00 per share. The warrant will be exercisable for 90 days from the date that the Class A common stock receives a trading symbol (the "New Dividend").
(2) To issue the previously announced and approved dividend that will issue 1 share of Class A common stock and 1 non-transferable share purchase warrant for each 10 shares of the Company's current common stock that they previously owned as of the record date of December 31, 2010. Each warrant will grant the holder to purchase an additional share of Class A common stock at a price of $1.00 per share. The warrant will be exercisable for 90 days from the date that the Class A common stock receives a trading symbol (the "Previous Dividend").
"It's exciting to see the outpour of support we have had thus far as we have progressed through the initial phases of this very important growth cycle. We appreciate the patience as we have been wading through an overwhelming amount of paperwork and bureaucratic processes in order to accomplish the goals we have set out with. On Friday, we will issue a statement to our shareholders to educate them on the process of receiving their dividend shares. We have some exciting new products coming out, and we will be announcing them after the dividend payout process is underway.
I recently returned from very successful trips to New York City, Washington D.C., and California. Some of our existing acquisitions are being completed and we expect to be announcing them in more detail soon.
With mounting interest in our financing, we have had our nose to the grindstone to complete additional presentation packages and paperwork. We recently welcomed several new top-shelf team members who will head up new drug development programs in addition to working to advance our current programs.
These developments help pave the way for the company to begin fulfilling its 'breakthrough drug development growth plan' and proposed NASDAQ up listing. It has been challenging for sure, but it makes us appreciate the success that much more," stated Mr. Raymond C. Dabney, President & CEO, Co-Founder, Cannabis Science, Inc.
Link: http://www.finanznachrichten.de/...ayouts-to-its-shareholders-256.htm